Loading...

Free Cash Flow Build Up

GW Pharmaceuticals Plc

GW Pharmaceuticals Plc (GWPH)

Healthcare

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue -----------
EBITDA -----------
EBIT -----------
Tax Rate ----0.75%-1.30%-0.28%-0.28%-0.28%-0.28%-0.28%
EBIAT -----------
Depreciation -----------
Accounts Receivable -----------
Inventories -----------
Accounts Payable -----------
Capital Expenditure -----------
UFCF -----------
WACC
PV UFCF -----
SUM PV UFCF -